Patents
Patents for C07C 255 - Carboxylic acid nitriles (27,066)
04/2004
04/07/2004EP1404637A2 Method for producing partial oxidation products and/or partial ammoxidation products of at least one olefinic hydrocarbon
04/07/2004EP1404633A1 Method for producing methacrolein from isobutane
04/07/2004EP1404328A1 Alpha-hydroxyamide statine derivatives for the treatment of alzheimer's disease
04/07/2004EP1404322A2 1-butane acid derivatives, pharmaceutical compositions containing said derivatives and the use thereof
04/07/2004EP1086074B1 New process
04/07/2004CN1487941A Synthesis of temozolomide and analogs
04/07/2004CN1487917A Method for making nitrile compounds from ethylenically unsaturated compounds
04/07/2004CN1487788A Pharmaceutical composition containing aminoacetonitril compounds and the use thereof for the preparation of a pharmacea-tical composition for the treatment of endoparasitic pests in animals
04/07/2004CN1144793C Polar-substituted hydrocarbons
04/07/2004CN1144781C Monoolefinc C5-mononitriles, method for production and use thereof
04/07/2004CN1144780C Process for producing 2,4,5-trifluorobenzonitrile
04/06/2004US6716832 Arylphenyl-substituted cyclic ketoenols
04/06/2004CA2190992C Naphthalene derivatives
04/01/2004WO2004026887A2 Estrogen receptor modulators
04/01/2004WO2004026821A2 Non-halogenated antibacterial agents and processes for making same
04/01/2004WO2004026812A2 Method for catalyst-free production of cyanophenols from methoxybenzonitriles
04/01/2004WO2004026462A1 System and method for the manufacture of hydrogen cyanide and acrylonitrile with simultaneous recovery of hydrogen
04/01/2004WO2004006352A3 Electronic devices made with electron transport and/or anti-quenching layers
04/01/2004WO2003101932A3 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
04/01/2004WO2003082777A3 Novel glucocorticoid receptor ligands
04/01/2004US20040063991 Method for making nitrile compounds from ethylenically unsaturated compounds
04/01/2004US20040063989 Preparation of at least one partial oxidation and/or ammoxidation product of propylene
04/01/2004US20040063988 Preparation of at least one partial oxidation and/or ammoxidation product of propylene
04/01/2004US20040063987 Method for producing alkoxymalononitriles
04/01/2004US20040063956 Hydrocyanation method for ethylenically unsaturated organic compounds
04/01/2004US20040063785 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use
04/01/2004US20040063783 Used to treat pathologies characterized by an oxidative stress condition and a lack of availability of endothelial nitrogen monoxide, such as ischemia, restenosis, erectile dysfunction, hypoxia, transplant rejection and diabetes
04/01/2004US20040063766 Pharmaceutical composition containing aminocetonitrile compounds and the use thereof for the preparation of a pharmaceutical composition for the treatment of endoparasitic pests in animals
04/01/2004US20040063760 Sodium channel modulatiors
04/01/2004US20040063686 Diabetes, major depression, manic depression, anxiety, schizophrenia, sleep disorders
04/01/2004US20040063671 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
04/01/2004US20040062941 Mixture of porous polymer and solid phase support; fine particle sizes; anchoring organic compounds
04/01/2004US20040062726 Novel photostabilizers, UV absorbers, and methods of photostabilizing a sunscreen composition
04/01/2004CA2498339A1 Estrogen receptor modulators
03/2004
03/31/2004EP1403264A1 Process for the industrial synthesis of 5-amino-3-carboxymethyl-4-cyano-2-thiophenecarboxydimethylester
03/31/2004EP1401451A2 Quinazoline derivatives which promote the release of parathyroid hormone
03/31/2004EP1401434A1 Modulators of peroxisome proliferator activated receptors (ppar)
03/31/2004EP0937030B1 3-amino-propoxyphenyl derivatives (i)
03/31/2004CN1143675C Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics
03/25/2004WO2004024707A2 Process for preparing amine type substituted benzofurans
03/25/2004WO2004024688A1 Substituted spirocyclic ketoenols
03/25/2004WO2004024676A1 Compounds for modulating the glycolosis enzyme complex and/or transaminase complex
03/25/2004WO2004024675A1 Substituted aminoethers for the treatment of alzheimer's disease
03/25/2004WO2004024147A1 4-(3,5-dicyanophenoxy) pyrazole derivatives for use as transcriptase modulators in the treatment of i.a. hiv
03/25/2004WO2003104167A3 Cyanohydrin ethers and esters as high-sensitivity enzyme substrates
03/25/2004WO2003041728A8 Novel phenyl-propargylether derivatives
03/25/2004WO2002088085A3 Methods and intermediates for preparing 4-aminoquinoline cetp inhibitors
03/25/2004US20040059157 Compound suitable for use as a catalyst or for producing a catalyst system derived from a bis-phosphorinane
03/25/2004US20040059148 Method for producing hydrolysis-stable ammonium nitriles
03/25/2004US20040059147 Novel process for preparing rac-bicalutamide and its intermediates
03/25/2004US20040059137 Method for producing compounds having a cf2o bridge
03/25/2004US20040059135 Process for the industrial synthesis of the methyl diester of 5-amino-3-carboxymethyl-4-cyano-2-thiophenecarboxylic acid, and application to the synthesis of bivalent salts of ranelic acid and their hydrates
03/25/2004US20040058916 Central nervous system disorders; psychological disorders; schizophrenia; antiarthritic agents; Alzheimer's disease; anticancer agents
03/25/2004US20040058820 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis
03/25/2004US20040057911 For protecting hair, skin and substrates such as polymers, textiles, fabrics, leathers and paints; cosmetics
03/25/2004DE10242080A1 Process for the catalyst-free production of cyanophenols comprises reaction of a substituted methoxybenzonitrile with an alkali metal alcoholate at a specified temperature
03/25/2004CA2498269A1 Substituted aminoethers for the treatment of alzheimer's disease
03/25/2004CA2498045A1 Compounds for modulating the glycolosis enzyme complex and/or transaminase complex
03/25/2004CA2496315A1 4-(3,5-dicyanophenoxy) pyrazole derivatives for use as reverse transcriptase modulators in the treatment of i.a. hiv
03/24/2004EP1399431A2 Novel nitriles useful as reversible inhibitors of cysteine proteases
03/24/2004EP1399146A1 Novel compounds and compositions as cathepsin inhibitors
03/24/2004EP1093389B1 Process for recovery of acrylonitirle
03/23/2004US6710207 Catalytic oxidation of mixtures of alkenes and alkanes in presence of mixed metal oxide containing molybdenum or tungsten
03/23/2004US6710205 Benzoic acid derivatives, processes for producing the same and drugs containing the same as the active ingredient
03/23/2004US6710201 Aminonitrile production
03/23/2004US6710200 Using reporter molecule derivative having aldehyde or ketone group detectable by fluorescence emission, ultraviolet radiation, absorptivity or colorimetric analysis; rearrangements
03/23/2004US6710089 Substituted N-fused-phenyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
03/23/2004US6710088 Inorganic ion receptor-active compounds
03/23/2004US6710011 Catalyst compositions for the ammoxidation of alkanes and olefins, methods of making and of using same
03/18/2004WO2004022526A1 Cathepsin cysteine protease inhibitors
03/18/2004WO2004022523A2 1, 3-diamino-2-hydroxypropane prodrug derivatives
03/18/2004WO2004006355A3 Charge transport compositions which are quinazoline derivatives and electronic devices made with such compositions
03/18/2004WO2003099763A8 N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors
03/18/2004WO2003099192A3 Bis-aromatic alkanols
03/18/2004WO2003097576A3 Diamino-functional chalcones
03/18/2004US20040054226 Alkylation of malonic ester, malononitrile; using carbonate and phase transfer agent
03/18/2004US20040054185 Antihistamines; cardiovascular disorders; cognition activators; Alzheimer's disease
03/18/2004US20040054105 Phosphorus-containing compositions and their use in hydrocyanation, isomerization and hydroformylation reactions
03/18/2004US20040054002 Compacted 2 2-dibromo-3-nitrilopropionamide
03/18/2004US20040053916 Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same
03/18/2004US20040053890 Naphthalene derivatives
03/18/2004US20040053786 Insecticidal 1,8-naphthalenedicarboxamides
03/18/2004US20040053378 Processes for making (R)-ethyl 4-cyano-3-hydroxybutyric acid
03/18/2004CA2497979A1 1, 3-diamino-2-hydroxypropane prodrug derivatives
03/18/2004CA2495939A1 Cathepsin cysteine protease inhibitors
03/17/2004EP1397370A1 B-benzyloxyaspartate derivatives with amino group on benzene ring
03/17/2004EP1397346A2 Method for the hemihydrogenation of dinitriles in order to form aminonitriles
03/17/2004EP1397345A2 Method for the hemihydrogenation of dinitriles in order to form aminonitriles
03/17/2004EP1397344A1 Process for preparation of cyclohexanol derivatives
03/17/2004EP1397340A2 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
03/17/2004EP1250311B1 Asymmetric synthesis of pregabalin
03/17/2004EP1144365B1 Inhibitors of alpha-4 beta-1 mediated cell adhesion
03/17/2004CN1483019A Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines
03/17/2004CN1483017A Process for the production of 1, 5-naphthalenediamine
03/16/2004US6706924 Process for the production of 1,5-naphthalenediamine
03/16/2004US6706918 3-cyano-2,4,5-trifluoro-benzoyl fluoride and intermediate products for the production thereof
03/16/2004US6706912 Carbon monoxide reacted with alcohol in presence of catalyst system comprising palladium cations, bidentate diphosphine, and anions derived from sulfonic acid, in apriotic solvent (anisole)
03/16/2004US6706881 Methods for preparing CETP inhibitors
03/16/2004US6706712 Cyclic derivatives as modulators of chemokine receptor activity
03/11/2004WO2004020414A1 Oxytocin inhibitors